FDA Investigator Kristy E Zuroski

Kristy E Zuroski has inspections in 3 countries as of 14 Sep 2023. Kristy E Zuroski has collaborated with a combinined 3664 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
98
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Alfred P Pistorio, Alison A Nicoli, Amos, Amy L Mcintyre, Amy M Cramer, Ana M Placencia, Ann L Demarco, Annemarie Bodnar, Anthony J Ladner, Anthony L Nicoli, Anthony P Duran, April L Brown, April L Young, Atul J Agrawal, Aurora Miha Trifanov, Baask, Benjamin W Anderson, Bill Tacket, Jr, Boun M Xiong, Bradley A Servais, Brian L Belz, Carolyn A Warren, Catherine M Vanderhoef, CDR Ileana Barreto Pettit, Charisse K Green, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Chhagan Tele, Christie A Soto, Christina A Castineyra, Como, Constance L Richard, Constance Lrichard Math, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dan Grabicki, Daniel J Grabicki, Darlene L Krieger, Darren D Holaday, Daryl A Dewoskin, David B Wieneke, David E Bailey, David J Ward, Demetria L Downs, Demetria L Lueneburg, Denise L Burosh, Dianna C Sonnenburg, Djamila Harouaka, Douglas J Snyder, Douglas W Atkins, Duc Minh H Nguyen, Edward A Fabiano, Eileen A Liu, Elizabeth P Mayer, Emest F Bizjak, Emily E Harlow, Emily E Markgraf, Eric A Breselow, Eric S Myskowski, Fannie M Harrell, Francis A Guidry, Frank S Sedzielarz, Frederick Razzaghi, Garrett W Steiner, Gina M Scholze, Graeme E Price, Grant M Ruis, Greg A Abel, Greg W Smith, Gregory W Smith, Hala L Selby, Heidi J Debeck, Howard A Burmester, Ivan E Reyes, Jaclyn N Munsch, Jacqueline Mdiaz Albertini, Jake T Lane, James A Beaulieu, James K Ireland, Jane E Nelson, Janis R Armedoriz, Jasjeet K Sekhon, Jeffry A Bernhardt, Jennifer Alongie Vollom, Jennifer L Huntington, Jennifer R Mathern, Jeremy L Tri, Jesse P Romenesko, Jessica L Johnson, Jessica M Novak, Joanne E King, Joel D Hustedt, John E Emmert, Jonathan G Gayechuway, Jonell R O'neil, Joseph M Edwin, Joy Rkozlowski Klena, Julie Woodberry, Justin A Boyd, Justine Tomasso, Karen M Jirele, Karen M Labounty, Karla J Youngberg, Katherine A Clarke Girolamo, Katherine Szestypalow, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kevin P Regan, Kibily D Dembele, Kimberly W Destromp, Krista K Petersen, Kristy A Zielny, Kristy Zivski, Larae M Koopman, Lauren E Merz, Lauren E Sanger, Lauren L Vajo, Laurimer Kuilan Torres, Lesley K Satterwhite, Leslie A Cartmill, Lily Y Koo, Linda V Weyer, Lisa M Lopez, Lloyd D Payne, M Edith Snyder, Mada A Tautges, Maere A Fadden, Margaret M Lubbers Solberg, Maria E Treadwell, Maria Estrella, Marian E Ramirez, Marie A Fadden, Maril A Fadden, Marissa S Steinhagen, Mark Sassaman, Mary M Finn, Matthew C Watson, Meghan Murphy, Melissa D Kalik, Melissa I Michurski, Melissa I Stittsworth, Michael R Goga, Michael Serrano, Mihaly S Ligmond, Mohammed H Adam, Monica E Caphart, Nicole C Shokatz, Nicole C Victoria, PhD, Paola E Lathrop, Parul M Patel, Paul L Bellamy, Peter T Erlandson, Ralph Jerndal, Ravindra K Kaallwal, Rebecca L Caulfield, Rebecca L Keller, Rebecca L Zamora, Richard Jay Tucker, RS, Richard W Koller, Robert C Steyert, Robert H Claflin, Robert J Waldorf, Rosario D'costa, Ross J Grigsby, S Lori Brown, PhD MPH, Sana A Elassar, Sandra A Hughes, Sandra Sejdinovic, Sarah A Palmer, Sarah E Mcmullen, Scott A Golladay, Scott L Schenian, Seth A Abbott, Shalonda C Clifford, Sharon K Thoma, PharmD, Shaun M Olson, Soyinka S Eneng, State Agency, Steven A Skaar, Steven M Weinman, Susan M Matthias, Susanne M Richardson, MSc RAC ELS, Tara C Singh, Tara M Humfeld, Tenzin Jangchup, Terrance L Scheiber, Theresa C Klaman, Thomas S Donaldson, Timothy G Philips, Traci C Kelm, Truong Xuan Nguyen (Andy), Victoria L Palmer, Virginia L Meeks, Walden H Lee, Wayne W Grundstrom, Wendy L Trefethren Grang, William E Keer, William P Fournier, Yehualashet A Gessesse, Zachary P Wachlarowicz, Zhaohui Ye

Kristy E Zuroski's Documents

Publish Date Document Type Title
February, 2000 EIR Gerber Products Company dba Nestle Nutrition-Eau Claire - EIR, 2000-03-03
June, 2000 EIR Hawkins, Inc. - EIR, 2000-06-29
May, 2000 FDA 483 Bimeda, Inc. - Form 483, 2000-05-17
July, 2000 FDA 483 Veterinary Pharmacy Corp. d.b.a. Vet Rx - Form 483, 2000-07-07
December, 2009 FDA 483 Coast Quality Pharmacy, LLC dba Anazao Health - Form 483, 2009-12-23
August, 2000 FDA 483 CIMA Laboratories, Inc. - Form 483, 2000-08-09
September, 2004 EIR EPIEN Medical, Inc. - EIR, 2004-09-30
December, 2002 FDA 483 Wayzata Bay Products, Inc. - Form 483, 2002-12-20
September, 2003 FDA 483 Veterinary Pharmacy Corporation - Form 483, 2003-09-09
June, 2001 EIR Tiro Industries, Inc. - EIR, 2001-06-05
May, 2000 EIR Bimeda, Inc. - EIR, 2000-05-17
May, 2003 FDA 483 Response Janssen Pharmaceuticals Inc. - Form 483R, 2003-06-02
June, 2000 FDA 483 Bell Pharmaceuticals, Inc. - Form 483, 2000-06-19
March, 2004 FDA 483 Wayzata Bay Products, Inc. - Form 483, 2004-03-24
January, 2008 FDA 483 Somerville Acquisitions Co., Inc. - Form 483, 2008-01-18
June, 2000 FDA 483 Hawkins, Inc. - Form 483, 2000-06-29
August, 2009 EIR Apotex Inc. - EIR, 2009-08-14
September, 2003 FDA 483 Response Veterinary Pharmacy Corporation - Form 483R, 2003-10-13
September, 2004 FDA 483 EPIEN Medical, Inc. - Form 483, 2004-09-30
August, 2009 FDA 483 Apotex Inc. - Form 483, 2009-08-14
October, 2003 EIR Upsher-Smith Laboratories, LLC - EIR, 2003-10-03
July, 2002 FDA 483 Modern Products, Inc. - Form 483, 2002-07-26
April, 2001 FDA 483 Apothecary Products, LLC - Form 483, 2001-04-05
September, 2000 EIR Cima Labs, Inc. - EIR, 2000-08-31
August, 2009 FDA 483 Response Apotex Inc. - Form 483R, 2009-09-03
May, 2003 FDA 483 Janssen Pharmaceuticals Inc. - Form 483, 2003-05-19
May, 2003 EIR Janssen Pharmaceuticals Inc. - EIR, 2003-05-19
April, 2004 FDA 483 Rochester Medical Corp - Form 483, 2004-04-21
September, 2000 FDA 483 Response Cima Labs, Inc. - Form 483R, 2000-08-18
September, 2003 EIR Veterinary Pharmacy Corporation - EIR, 2003-09-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more